MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma.
Liu G, Zhou W, Wang LI, Park S, Miller DP, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma. Cancer Lett. 2004 Oct 08; 214(1):69-79.